Avidity Biosciences, Inc is a San Diego-based biotechnology company that is revolutionizing targeted RNA therapeutics through their innovative Antibody Oligonucleotide Conjugates (AOC) platform. By combining the specificity of monoclonal antibodies with the precision of oligonucleotides, Avidity is able to effectively target the underlying genetic drivers of diseases and deliver treatment options for patients and their families.
Driven by their mission to profoundly improve people's lives, Avidity is focused on tackling the root cause of diseases, starting with their muscle disease franchise. With an agile and diverse team, they are advancing and expanding their pipeline programs to address unmet patient needs across a wide range of therapeutic areas, aiming to bring about a new class of RNA therapeutics.
Generated from the website